Examination, validation and translation of signaling networks of cellular radiation response
Recruiting
- Conditions
- C10C13C32Malignant neoplasm of oropharynxMalignant neoplasm of hypopharynxMalignant neoplasm of larynx
- Registration Number
- DRKS00012947
- Lead Sponsor
- niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Histologically confirmed carcinoma of the oral cavity, the oropharynx, hypopharynx or larynx; planned radiation therapy in the head-neck-area according to a standardized protocol (cisplatin-based radiochemotherapy, radiation dose 60-70 Gy, fractionation 5 x 2 Gy / week); written consent
Exclusion Criteria
Complete removal of major salivary glands in the context of surgical tumor therapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prediction of individual, i.e. patient-specific side effects and tumor control during / after radiation therapy
- Secondary Outcome Measures
Name Time Method